CytoRecovery
Blacksburg, US · Founded 2017 · Delaware corporation · 1 known investors
Cyto Recovery develops technology for label-free cell sorting and gentle sample cleanup for cell populations, aimed at life-science and research users. Its products are positioned as tools for separating and purifying cells without labeling.
Founders & leadership
SC
Stephen C. TurnerCEO, President, Secretary
Board
JR
James RameyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$3.9M disclosed across 3 rounds · 2018–2022
▶$2.1MraisedJul 2022 · 24 investors · BiotechnologyRule 506(b)
▶$2.1MraisedJul 2022 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vinod ChachraDirector
- James RameyDirector
- Stephen C. TurnerExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2.1M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.3MraisedApr 2021 · 29 investors · BiotechnologyRule 506(b)
▶$1.3MraisedApr 2021 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen C. TurnerExecutive Officer, Director
- James RameyDirector
- Offering amount
- $1.8M
- Amount sold
- $1.3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$500KraisedApr 2019 · 13 investors · Other TechnologyRule 506(b)
▶$500KraisedApr 2019 · 13 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Leonard P. HarrisDirector
- Stephen C. TurnerExecutive Officer, Director
- James RameyDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Akadeum Life Sciences14 shared keywordsAkadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.
Danaher10 shared keywordsDanaher is a diversified conglomerate that operates a portfolio of businesses in life sciences, diagnostics, and related fields, guided by its Danaher Business System (DBS) operating model.
Abcam9 shared keywordsSupplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.
NanoCellect8 shared keywordsNanoCellect develops microfluidic-based cell sorters that operate at low pressure to sort cells with high viability and reduced shear stress, aimed at scientists and researchers. Its products use disposable, sterile microfluidic cartridges for applications such as single-cell sorting and stem cell research.
Companies competing with CytoRecovery for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does CytoRecovery do?
- Cyto Recovery develops technology for label-free cell sorting and gentle sample cleanup for cell populations, aimed at life-science and research users. Its products are positioned as tools for separating and purifying cells without labeling.
- Who are CytoRecovery's investors?
- CytoRecovery's investors include The Launch Place.
- How much funding has CytoRecovery raised?
- CytoRecovery has disclosed $3.9M raised across 3 rounds.
- Where is CytoRecovery headquartered?
- CytoRecovery is headquartered in Blacksburg, US.